Men with newly diagnosed metastatic, hormone-sensitive prostate cancer lived more than a year longer when they received a chemotherapy drug as initial treatment instead of waiting to for the disease to become resistant to hormone-blockers, report...
1-Jun-2014 7:30 AM EDT
Clinical Trial Analysis Suggests Drug Combination May Be Highly Effective in Recurrent Ovarian Cancer
Significant improvement with the use of a combination drug therapy for recurrent ovarian cancer was reported at the annual meeting of the American Society of Clinical Oncology (ASCO) meeting in Chicago.
31-May-2014 4:00 PM EDT
Dana-Farber researchers have identified antibodies against the deadly Middle East Respiratory Syndrome that could lead to prevention/treatment for the virus with a 40% mortality rate
25-Apr-2014 4:00 PM EDT
In 2004, a team of Dana-Farber doctors discovered a gene mutation that could treated by a drug on the market for something else. This discovery transformed the way lung cancer is treated and began an era of precision medicine for lung cancer.
23-Apr-2014 12:40 PM EDT
Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration (FDA) approved the first targeted drug as treatment for advanced stomach cancer.
21-Apr-2014 5:00 PM EDT
A new study by researchers at Dana-Farber Cancer Institute suggests that not all doctors are ready to embrace tests that look for hundreds of DNA changes in patients’ tumor samples, while others plan to offer this type of cancer gene testing to...
21-Mar-2014 4:00 PM EDT
A patient with advanced bladder cancer in a phase I trial had a complete response for 14 months to a combination of the targeted drugs everolimus and pazopanib, and genomic profiling of his tumor revealed two alterations that may have led to this...
12-Mar-2014 12:30 PM EDT
Study Shows More Hospital Deaths and Invasive Care for Dying Cancer Patients Who Receive Chemotherapy
A study by researchers at Dana-Farber Cancer Institute and Weill Cornell Medical College shows terminal cancer patients who receive chemotherapy in the last months of their lives are less likely to die where they want and are more likely to undergo...
28-Feb-2014 11:00 AM EST
With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
5-Mar-2014 5:00 PM EST
11-Nov-2013 5:00 PM EST
National Cancer Report Underscores Need for Research Funding; Dana-Farber Expert Says Scientific Advances Merit Support
17-Sep-2013 3:00 PM EDT
The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
7-Jun-2013 12:00 PM EDT
24-May-2013 3:00 PM EDT
Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
17-May-2013 8:00 AM EDT
The holidays are almost here and festive food is everywhere. “While these foods are delicious to eat, some have the added bonus of containing cancer-preventing nutrients,” says Stephanie Meyers, MS, RD/LDN, a nutritionist at Dana-Farber Cancer...
23-Oct-2009 1:00 PM EDT